Back to search

Article

Phosphorylation of the M1 muscarinic acetylcholine receptor mediates protection in neurodegenerative disease

2021-04-29

Abstract excerpt

There are currently no treatments that can slow the progression of neurodegenerative diseases such as Alzheimer’s disease (AD). There is, however, a growing body of evidence that activation of the M1 muscarinic acetylcholine receptor (M1-receptor) can not only restore memory loss in AD patients, but in preclinical animal models can also slow neurodegenerative disease progression. The generation of an effective med...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4e1e5500-88c7-5be2-9808-ec600ef37817
DOI
10.1101/2021.04.29.440753
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Phosphorylation of the M1 muscarinic acetylcholine receptor mediates protection in neurodegenerative diseaseDOI 10.1101/2021.04.29.440753
Select a neighboring publication to make it the new centre.